Results 151 to 160 of about 4,314 (270)

Dexamethasone induced Dectin-1 activation enhances NLRP3 inflammasome activation. [PDF]

Front Immunol
Koerber RM, Oberbeck S, Kotthoff P, Daecke SN, Brossart P, Held SAE.   +5 more
europepmc   +1 more source

The adjunction problem over torsion-free groups. [PDF]

Proc Natl Acad Sci U S A, 2005
Forester M, Rourke C.
europepmc   +1 more source

MELK is an oncogenic kinase essential for metastasis, mitotic progression, and programmed death in lung carcinoma. [PDF]

Signal Transduct Target Ther, 2020
Tang Q, Li W, Zheng X, Ren L, Liu J, Li S, Wang J, Du G.   +7 more
europepmc   +1 more source

Transcriptional profiling of circulating extracellular vesicles from prebiopsy prostate cancer patients

Molecular Oncology, EarlyView.
RNA profiling of circulating extracellular vesicles (EVs) from blood samples of men undergoing prostate biopsy identifies transcripts associated with clinically significant prostate cancer. Integrative analysis with public tumor datasets links EV‐derived gene signatures to tumor stage and progression‐free survival, highlighting CASP3, XRCC2, and RIT1 ...
Stefan Werner, Pierre Tennstedt, Randi C. Pose, Christian Müller, Katharina Besler, Svenja Schneegans, Malik Alawi, Marie C. Roesch, Sven Peine, Desiree Bonci, Joanna Budna‐Tukan, Evi Lianidou, Catherine Alix‐Panabières, Derya Tilki, Klaus Pantel   +14 more
wiley   +1 more source

Toward a knowledge-synthesis heuristic for sport leaders: the strategic leader synthesis model. [PDF]

Front Sports Act Living
Cairney J, Richard V, Legg D.
europepmc   +1 more source

An ontologically founded architecture for information systems in clinical and epidemiological research. [PDF]

J Biomed Semantics, 2011
Uciteli A, Groß S, Kireyev S, Herre H.
europepmc   +1 more source

Metastasis on pause: How dormant tumor cells stay hidden within the tumor microenvironment and evade immune surveillance

Molecular Oncology, EarlyView.
Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary, Jose Javier Bravo‐Cordero   +1 more
wiley   +1 more source

A Verified ODE Solver and the Lorenz Attractor. [PDF]

J Autom Reason, 2018
Immler F.
europepmc   +1 more source

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

Molecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska, Stephany Gallardo, Nur S. Zainal, Leena Arora, Matthew Ellis, Maria‐Antoinette Lopez, Judith Austine, Sai Pittla, Serena J Chee, Aiman Alzetani, Emily C Shaw, Christian H Ottensmeier, Gareth J Thomas, Christopher J Hanley   +13 more
wiley   +1 more source

Postcards from the past: the Third SICOT Congress, Bologna 1936. [PDF]

Int Orthop, 2014
Di Matteo B, Tarabella V, Filardo G, Viganò A, Tomba P, Marcacci M.   +5 more
europepmc   +1 more source